Drug compound could be next-generation treatment for aggressive form of leukemia

Researchers have been struggling for years to find a treatment for patients who have a recurrence of acute myeloid leukemia (AML), an aggressive blood cancer that is one of the most lethal cancers. About 19,520 news cases are diagnosed a year, and about 10,670 people a year die from it, according to the American Cancer Society.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news